- Home
- TRUE vs CYBN Comparison
TRUE vs CYBN Comparison
Compare TRUE & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRUE
- CYBN
- Stock Information
- Founded
- TRUE 2005
- CYBN 2019
- Country
- TRUE United States
- CYBN Canada
- Employees
- TRUE N/A
- CYBN N/A
- Industry
- TRUE Computer Software: Programming Data Processing
- CYBN Pharmaceuticals and Biotechnology
- Sector
- TRUE Technology
- CYBN Health Care
- Exchange
- TRUE Nasdaq
- CYBN Nasdaq
- Market Cap
- TRUE 175.1M
- CYBN 176.5M
- IPO Year
- TRUE 2014
- CYBN N/A
- Fundamental
- Price
- TRUE $1.60
- CYBN $6.22
- Analyst Decision
- TRUE Hold
- CYBN Strong Buy
- Analyst Count
- TRUE 5
- CYBN 3
- Target Price
- TRUE $3.33
- CYBN $85.00
- AVG Volume (30 Days)
- TRUE 348.8K
- CYBN 717.1K
- Earning Date
- TRUE 11-05-2025
- CYBN 11-12-2025
- Dividend Yield
- TRUE N/A
- CYBN N/A
- EPS Growth
- TRUE N/A
- CYBN N/A
- EPS
- TRUE N/A
- CYBN N/A
- Revenue
- TRUE $184,559,000.00
- CYBN N/A
- Revenue This Year
- TRUE $8.42
- CYBN N/A
- Revenue Next Year
- TRUE $5.64
- CYBN N/A
- P/E Ratio
- TRUE N/A
- CYBN N/A
- Revenue Growth
- TRUE 11.66
- CYBN N/A
- 52 Week Low
- TRUE $1.05
- CYBN $4.81
- 52 Week High
- TRUE $4.62
- CYBN $13.88
- Technical
- Relative Strength Index (RSI)
- TRUE 35.47
- CYBN 47.09
- Support Level
- TRUE $1.51
- CYBN $5.93
- Resistance Level
- TRUE $1.89
- CYBN $6.63
- Average True Range (ATR)
- TRUE 0.13
- CYBN 0.34
- MACD
- TRUE -0.07
- CYBN 0.07
- Stochastic Oscillator
- TRUE 8.54
- CYBN 46.71
About TRUE TrueCar Inc.
TrueCar Inc is a data-driven online platform operating on common technology infrastructure, powered by proprietary data and analytics. It also customizes and operates its platform for affinity group marketing partners, including financial institutions like PenFed and American Express; membership-based organizations like Consumer Reports, AARP, Sam's Club, and AAA; and employee buying programs for large enterprises such as IBM and Walmart. The Company has one operating segment, with three distinct service offerings: Dealer products and services, OEM incentives, and other.
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.